SEC Form 4 · accession 0001609351-16-000045
Spark Therapeutics, Inc. · ONCE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stephen W Webster
Officer — Chief Financial Officer
Period of report
May 20, 2016
Accepted (ET)
May 24, 2016 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001609351
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 20, 2016 | M | 20,000 | $3.45 | A | 22,500 | D | |
| Common Stock | May 20, 2016 | S | 11,000 | $50.40 | D | 11,500 | D | |
| Common Stock | May 20, 2016 | S | 9,000 | $50.38 | D | 2,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.45 | May 20, 2016 | M | 20,000 | D | — | Jul 7, 2024 | Common Stock | 20,000 | 146,015 | D |
Explanation of responses
- F1This option was granted on July 7, 2014 and vests over four years, with 25% of the shares underlying the option vesting on July 7, 2015, and the remainder vesting quarterly thereafter.